monosialoganglioside

Small moleculeexperimental

Clinical trial activity

5 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
4
Phase 3
2
Phase 4
1

Earliest trial started Oct 1, 2013 (NCT01882621)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetSupplementation

    supplementation

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • monosialoganglioside
  • monosialoganglioside

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04952064Phase 4Jul 28, 2021Central South University, People's Liberation Army of China
NCT06742216Phase 3Nov 3, 2020Qilu Pharmaceutical Co., Ltd.
NCT03067753Phase 2Dec 1, 2016Zhejiang University
NCT02500810Phase 2Jul 1, 2015Capital Medical University, Chinese Academy of Medical Sciences, Peking University, People's Liberation Army of China, Qingdao University, Tsinghua University, Weifang People's Hospital
NCT01882621Phase 3Oct 1, 2013Southern Medical University, Sun Yat-Sen University
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
People's Liberation Army of ChinaGovernment2122015
Capital Medical UniversityAcademic/Hospital1012015
Central South UniversityAcademic/Hospital1012021
Chinese Academy of Medical SciencesAcademic/Hospital1012015
Peking UniversityAcademic/Hospital1112015
Qilu Pharmaceutical Co., Ltd.For profit1112020
Qingdao UniversityAcademic/Hospital1012015
Southern Medical UniversityAcademic/Hospital1012013
Sun Yat-Sen UniversityAcademic/Hospital1112013
Tsinghua UniversityAcademic/Hospital1012015
Weifang People's HospitalAcademic/Hospital1012015
Zhejiang UniversityAcademic/Hospital1112016
12 organizations
Page 1 / 1